Inossia

Inossia

Inossia has invented and patented the Inossia® Cement Softener to make bone cements softer and better adapted to brittle bone. The soft bone cement can be used both to treat fractures in the spine and to treat painful degenerated discs.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor

€0.0

Valuation: €0.0

round

€50.0k

Grant
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021
Revenues0000000000000000
% growth-(52 %)(79 %)-
EBITDA0000000000000000
% EBITDA margin--(2186 %)-
Profit0000000000000000
% profit margin--(2622 %)-
EV0000000000000000
EV / revenue00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x
R&D budget0000000000000000

Source: Company filings or news article

More about Inossia
Made with AI
Edit

Operator of a fully modular healthcare platform intended to improve patient care. The company's platform supports all staff in their daily work and additionally enables the development and use of innovations such as artificial intelligence, Big Data, telemedicine, patient applications and wearables to fundamentally improve patient care and research, enabling hospitals and clinics to increase the efficiency of processes.

Keywords: Healthcare Devices, Services, Supplies, Bone Cement, Collapsed Adjacent Vertebrae, Collapsed Vertebra, Fracture Treatment Softener, Fragile Skeletons, Osteoporosis Care, Vertebral Fracturing.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo